US FDA’s Pazdur On When And Why US Patients Must Satisfy Trial Diversity Requirements

Flexibility on the geographic location of clinical trial participants will depend on the underlying reasons the FDA wants diversity in the study, the agency’s Oncology Center of Excellence Director said.